MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0080040
Dipali Enterprises Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹27.13 Cr
▲ 6.14% YoY
Net loss · FY 2025
₹1.98 Lakh
Net margin -0.1%
EBITDA · FY 2025
₹19.46 Lakh
EBITDA margin 0.7%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Satisfied charges
₹11.5 Cr
No open charges
Company age
28 yrs
Est. 1998
Employees · EPFO
8
Provident fund records
About Dipali Enterprises Private Limited
Data last updated:
Dipali Enterprises Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 10 February 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51397MH1998PTC113488. Its GSTIN is 27AAACD4194K1ZF (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Jitendra Ramniklal Doshi and Dipak Kantilal Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A/101 Krishna Nagari S.V.Road Borivali(West), Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.13 Cr. For the same year it recorded a net loss of ₹1.98 Lakh (net margin -0.1%) and EBITDA of ₹19.46 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹11.5 Cr on record. Court records list 22 cases involving the company, including 19 filed by the company and 3 filed against it; 6 cases are pending.
Dipali Enterprises Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0080040). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dipalienterprisespvtltd.com.
Company details
CIN U51397MH1998PTC113488
Registration Number 113488
Incorporation Date 10 February 1998
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0080040
Recognitions & Rankings of Dipali Enterprises
Contact details
Dipali Enterprises Private Limited's registered office is in Mumbai, Maharashtra. Its website is dipalienterprisespvtltd.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA/101 Krishna Nagari S.V.Road Borivali(West), Mumbai, Maharashtra, India – 400092
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dipali Enterprises Private Limited, buy the company report.
Comprehensive company report
Dipali Enterprises Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dipali Enterprises is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Dipali Enterprises Private Limited, buy the company report.
Financials of Dipali Enterprises Private Limited
FY 2025 filings availableDipali Enterprises Private Limited reported revenue of ₹27.13 Cr for FY 2025.
Revenue · FY 2025
₹27.13 Cr
Net loss · FY 2025
₹1.98 Lakh margin -0.1%
EBITDA · FY 2025
₹19.46 Lakh margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▲ 3%
EBITDA CAGR growth
1 year
▲ 18%
3 years · compounded
▼ 13%
5 years · compounded
▼ 13%
Revenue has grown at a compounded annual rate (CAGR) of 3% over three years. EBITDA rose 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.46 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.98 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dipali Enterprises Private Limited, buy the company report.
Board of directors of Dipali Enterprises Private Limited
Dipali Enterprises has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Ramniklal Doshi | Director | 10 Feb 1998 | 28 Years 8 Months | Current |
| Dipak Kantilal Shah | Director | 10 Feb 1998 | 28 Years 8 Months | Current |
Peer comparison
Dipali Enterprises Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sivam Remedies Private Limited | ₹27.3 Cr (FY 2025) | 27.0% | Chennai, Tamil Nadu, India | |||
| Nexus Lifecare Private Limited | ₹27.24 Cr (FY 2025) | -21.0% | Mumbai, Maharashtra, India | |||
| Dipali Enterprises Private Limitedthis company | ₹27.13 Cr (FY 2025) | -₹1.98 Lakh | -0.1% | 8 | Mumbai, Maharashtra, India | |
| Neomi Pharmaceuticals Private Limited | ₹27.12 Cr (FY 2025) | -12.0% | Mumbai, Maharashtra, India | |||
| Izek Healthcare Private Limited | ₹27.1 Cr (FY 2025) | 56.0% | New Delhi, Delhi, India | |||
| Ism Corporation Private Limited | ₹27.06 Cr (FY 2025) | 513.0% | New Delhi, Delhi, India | |||
| Aditya Generic(Drugs) Private Limited | ₹26.96 Cr (FY 2024) | 2.0% | Tezpur, Assam, India |
To see the full peer comparison of Dipali Enterprises Private Limited, buy the company report.
Auditor
Dipali Enterprises Private Limited is audited by Rask& Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Rask& Associates | FY 2024 | 151014 |
Shareholding
The shareholding of Dipali Enterprises Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dipali Enterprises Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹11.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Apr 2015 | 10576623 | Hdfc Bank Limited | ₹3.5 Cr | Satisfied | |
| 09 Dec 2014 | 10545073 | Hdfc Bank Limited | ₹4 Cr | Satisfied | |
| 01 Jun 2001 | 90143429 | The Kapol Co-Op. Bank Ltd. | ₹4 Cr | Satisfied |
To see the full charge records of Dipali Enterprises Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Dipali Enterprises Private Limited has 22 court cases on record: 19 filed by Dipali Enterprises, 3 filed against it. 6 cases are pending and 16 are disposed.
Total cases
22
Filed by the company
19
Filed against the company
3
Pending
6
Disposed
16
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 22 | 3 | 6 |
Cases on record (5 of 22)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SW CASES W) | Filed by the company against Pureca Laboratories P Ltd and 2 Others | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Court case (Cri.Appeal) | Filed against the company by M/S. Vexta Laboratories Pvt. Ltd. and Anr. and 1 other | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed by the company against M/S Somil Enterprises Pvt Ltd | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SS CASES S) | Filed by the company against Ms Arvind Remedies Ltd and 2 others | Disposed |
| District court, Ludhiana, Punjab | Commercial suit | Filed by the company against Ms Ion Healthcare Pvt Ltd | Disposed |
To see the full case history of Dipali Enterprises Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Dipali Enterprises Private Limited has 10 MSME Form 1 returns on record between 2020 and 2024, listing 93 overdue payments to 16 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 16)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Brundavan Laboratories Private Limited | |||
| Anphar Laboratories Private Limited | |||
| Prudence Pharma Chem | |||
| B. Sharda Pharma-Chem Limited | |||
| Palam Pharma Private Limited |
To see the full MSME payment records of Dipali Enterprises Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Dipali Enterprises Private Limited has a workforce of 8 employees on its EPFO records as of Mar 23, 2024, across 3 active EPFO establishments.
Employee count
8
Active EPFO establishments
3
GST
Dipali Enterprises has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACD4194K1ZF | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dipali Enterprises Private Limited, buy the company report.
Recent activity
Dipali Enterprises Private Limited has 3 board changes on record since 1998: 2 appointments and 1 cessation. The latest: Himanshoo Jitendra Doshi ceased to be Director on 08 Apr 2023.
AGM
Dipali Enterprises Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dipali Enterprises Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 28 Apr 2015 via Charge ID 10576623 with Hdfc Bank Limited was fully satisfied on 05 Jan 2024.
Charges
A charge registered on 09 Dec 2014 via Charge ID 10545073 with Hdfc Bank Limited was fully satisfied on 05 Jan 2024.
Ceased
Himanshoo Jitendra Doshi ceased to be Director.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 350.00 Lakh with Charge ID 10576623 was registered on 28 Apr 2015.
Charges
A charge registered on 01 Jun 2001 via Charge ID 90143429 with The Kapol Co-Op. Bank Ltd. was fully satisfied on 04 Apr 2015.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 400.00 Lakh with Charge ID 10545073 was registered on 09 Dec 2014.
Charges
A charge with The Kapol Co-Op. Bank Ltd. of Rs. 400.00 Lakh registered on 01 Jun 2001 with Charge ID 90143429 was modified on 29 Nov 2012.
Charges
A charge with The Kapol Co-Op. Bank Ltd. amounted to Rs. 400.00 Lakh with Charge ID 90143429 was registered on 01 Jun 2001.
Appointed
Dipak Kantilal Shah was appointed as Director.
Appointed
Jitendra Ramniklal Doshi was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Dipali Enterprises is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 10 February 1998 (28+ years old) and is registered under CIN U51397MH1998PTC113488.
Dipali Enterprises has 2 current directors:
- Jitendra Ramniklal Doshi - Director
- Dipak Kantilal Shah - Director
The latest financial statements of Dipali Enterprises on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dipali Enterprises is 27AAACD4194K1ZF, registered in Maharashtra.
The CIN (Corporate Identification Number) of Dipali Enterprises is U51397MH1998PTC113488. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dipali Enterprises has 22 court cases on record: 19 filed by the company and 3 filed against it. 6 are pending.
Dipali Enterprises was incorporated on 10 February 1998, making it 28+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Dipali Enterprises by revenue are Sivam Remedies Private Limited, Nexus Lifecare Private Limited, Neomi Pharmaceuticals Private Limited, Izek Healthcare Private Limited, Ism Corporation Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Himanshoo Jitendra Doshi ceased to be Director on 08 Apr 2023. Dipak Kantilal Shah was appointed as Director on 10 Feb 1998. Jitendra Ramniklal Doshi was appointed as Director on 10 Feb 1998.
Yes, Dipali Enterprises is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0080040).
Dipali Enterprises has 10 MSME Form 1 returns on record between 2020 and 2024, listing 93 overdue payments to 16 micro and small suppliers. The latest return was filed on 27 Apr 2024.
Dipali Enterprises can be reached through the website dipalienterprisespvtltd.com. Its registered office is in Mumbai, Maharashtra, India.